Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma. Issue 1 (January 2020)
- Record Type:
- Journal Article
- Title:
- Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma. Issue 1 (January 2020)
- Main Title:
- Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
- Authors:
- Ye, Liangtao
Kriegl, Lydia
Reiter, Florian P.
Munker, Stefan M.
Itzel, Timo
Teufel, Andreas
Ziesch, Andreas
Török, Helga Paula
Kirchner, Thomas
Gerbes, Alexander L.
Guba, Markus
Mayerle, Julia
De Toni, Enrico N. - Abstract:
- Abstract : OBJECTIVES: Hepatocellular carcinoma (HCC) is a leading cancer-related cause of death. Unfortunately, recurrence is common even after curative treatment of early-stage patients, and no adjuvant treatment has yet been established. Aberrant expression of OLFM4 in human cancers has been reported; yet, its specific function during tumor development remains poorly understood, and its role in HCC is unknown. The purpose of this study is to examine the prognostic significance of OLFM4 and its functional relevance in determining recurrence in patients with early-stage HCC. METHODS: Immunohistochemical staining to assess expression, cellular distribution, and prognostic significance of OLFM4 was performed in a tissue microarray comprising 157 HCC tissues and matched nontumor tissues. In addition, expression of OLFM4-coding mRNA was assessed in a separate patients' cohort. The findings were validated by in vitro functional studies using siRNA directed against OLFM4 to assess its effect on cell motility and proliferation. RESULTS: The fraction of HCC samples exhibiting positive OLFM4 staining was higher in comparison with that observed in hepatocytes from matched nontumor tissue (61% vs 39%). However, cytoplasmic-only staining for OLFM4 was associated with vascular invasion ( P = 0.048), MMP-7 expression ( P = 0.002), and poorer survival ( P = 0.008). A multivariate analysis confirmed the independent significance of OLFM4 in determining patients' outcome (5-year survivalAbstract : OBJECTIVES: Hepatocellular carcinoma (HCC) is a leading cancer-related cause of death. Unfortunately, recurrence is common even after curative treatment of early-stage patients, and no adjuvant treatment has yet been established. Aberrant expression of OLFM4 in human cancers has been reported; yet, its specific function during tumor development remains poorly understood, and its role in HCC is unknown. The purpose of this study is to examine the prognostic significance of OLFM4 and its functional relevance in determining recurrence in patients with early-stage HCC. METHODS: Immunohistochemical staining to assess expression, cellular distribution, and prognostic significance of OLFM4 was performed in a tissue microarray comprising 157 HCC tissues and matched nontumor tissues. In addition, expression of OLFM4-coding mRNA was assessed in a separate patients' cohort. The findings were validated by in vitro functional studies using siRNA directed against OLFM4 to assess its effect on cell motility and proliferation. RESULTS: The fraction of HCC samples exhibiting positive OLFM4 staining was higher in comparison with that observed in hepatocytes from matched nontumor tissue (61% vs 39%). However, cytoplasmic-only staining for OLFM4 was associated with vascular invasion ( P = 0.048), MMP-7 expression ( P = 0.002), and poorer survival ( P = 0.008). A multivariate analysis confirmed the independent significance of OLFM4 in determining patients' outcome (5-year survival [58.3% vs 17.3%; HR: 2.135 {95% confidence interval: 1.135–4.015}; P = 0.019]). Correspondingly, inhibition of OLFM4 by siRNA modulated the expression of MMP-7 and E-cadherin, causing inhibition of cell proliferation, motility, and migration. DISCUSSION: To the best of our knowledge, we provide the first report on the prognostic significance of OLFM4 in HCC and identify its mechanistic role as crucial mediator of MMP family protein and E-Cadherin in determining cell invasion and metastasis formation. … (more)
- Is Part Of:
- Clinical and translational gastroenterology. Volume 11:Issue 1(2020)
- Journal:
- Clinical and translational gastroenterology
- Issue:
- Volume 11:Issue 1(2020)
- Issue Display:
- Volume 11, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 11
- Issue:
- 1
- Issue Sort Value:
- 2020-0011-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-01
- Subjects:
- Stomach -- Diseases -- Periodicals
Intestines -- Diseases -- Periodicals
Gastroenterology
Gastrointestinal Diseases
Liver Diseases
Intestines -- Diseases
Stomach -- Diseases
Periodical
Periodicals
Fulltext
Internet Resources
Periodicals
Electronic journals
616.33 - Journal URLs:
- http://bibpurl.oclc.org/web/52768 ↗
http://www.nature.com/ctg ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/1564/ ↗
https://journals.lww.com/ctg/pages/default.aspx ↗
http://www.nature.com/ ↗ - DOI:
- 10.14309/ctg.0000000000000124 ↗
- Languages:
- English
- ISSNs:
- 2155-384X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15930.xml